Referred to the House Committee on Energy and Commerce.
Email me when HR 9169 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 9169. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill orders the National Institutes of Health to increase basic, translational, and clinical research on polycystic kidney disease (PKD) and to work with partners across government, academia, and industry. It also requires a working group to develop a comprehensive PKD research roadmap and report its findings to Congress within two years. The goal is to accelerate treatments for the roughly 500,000 Americans affected by this costly, life‑threatening disease.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 9169
3 free questions a day, no accountSponsors
- Rep. Wasserman Schultz, Debbie [D-FL-25] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 9169 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 9169 freeOr ask your AI assistant about HR 9169 directly:
Add to Claude, ChatGPT or Cursor